ArticleCancer immunology, immunotherapy : CII2012

Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.

A C S A Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.